Douglas G. Altman

829.5k total citations · 91 hit papers
655 papers, 618.4k citations indexed

About

Douglas G. Altman is a scholar working on Statistics, Probability and Uncertainty, Economics and Econometrics and Statistics and Probability. According to data from OpenAlex, Douglas G. Altman has authored 655 papers receiving a total of 618.4k indexed citations (citations by other indexed papers that have themselves been cited), including 345 papers in Statistics, Probability and Uncertainty, 182 papers in Economics and Econometrics and 138 papers in Statistics and Probability. Recurrent topics in Douglas G. Altman's work include Meta-analysis and systematic reviews (331 papers), Health Systems, Economic Evaluations, Quality of Life (177 papers) and Statistical Methods in Clinical Trials (100 papers). Douglas G. Altman is often cited by papers focused on Meta-analysis and systematic reviews (331 papers), Health Systems, Economic Evaluations, Quality of Life (177 papers) and Statistical Methods in Clinical Trials (100 papers). Douglas G. Altman collaborates with scholars based in United Kingdom, United States and Canada. Douglas G. Altman's co-authors include David Moher, Jennifer Tetzlaff, Alessandro Liberati, Peter C Gøtzsche, Julian P. T. Higgins, A. Liberati, Jonathan J Deeks, Matthias Egger, Stuart Pocock and Simon G. Thompson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Douglas G. Altman

645 papers receiving 607.7k citations

Hit Papers

Preferred reporting items... 1983 2026 1997 2011 2009 2009 2003 2009 2009 20.0k 40.0k 60.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
    2009 74.1k citations David Moher, Douglas G. Altman et al. BMJ profile →
  2. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
    2009 52.0k citations David Moher, Douglas G. Altman et al. profile →
  3. Measuring inconsistency in meta-analyses
    2003 49.6k citations Jonathan J Deeks, Douglas G. Altman et al. BMJ profile →
  4. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
    2009 43.1k citations David Moher, Douglas G. Altman et al. profile →
  5. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
    2009 24.4k citations Douglas G. Altman, Cynthia D. Mulrow et al. profile →
  6. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
    2007 18.0k citations Erik von Elm, Douglas G. Altman et al. profile →
  7. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
    2009 16.2k citations David Moher, Douglas G. Altman et al. Journal of Clinical Epidemiology profile →
  8. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
    2007 12.4k citations Erik von Elm, Douglas G. Altman et al. Annals of Internal Medicine profile →
  9. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
    2007 11.6k citations Erik von Elm, Douglas G. Altman et al. profile →
  10. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
    2010 10.8k citations Kenneth F. Schulz, Douglas G. Altman et al. profile →
  11. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
    2008 10.1k citations Erik von Elm, Douglas G. Altman et al. Journal of Clinical Epidemiology profile →
  12. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
    2010 9.7k citations David Moher, Douglas G. Altman et al. profile →
  13. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
    2009 8.8k citations Douglas G. Altman, Cynthia D. Mulrow et al. Journal of Clinical Epidemiology profile →
  14. Practical Statistics for Medical Research
    1990 8.5k citations Douglas G. Altman profile →
  15. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
    2009 8.4k citations Douglas G. Altman, Cynthia D. Mulrow et al. Annals of Internal Medicine profile →
  16. Measuring agreement in method comparison studies
    1999 7.2k citations Douglas G. Altman et al. profile →
  17. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
    2014 6.8k citations Erik von Elm, Douglas G. Altman et al. profile →
  18. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
    2014 6.5k citations Isabelle Boutron, David Moher et al. profile →
  19. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
    2007 6.2k citations Erik von Elm, Douglas G. Altman et al. BMJ profile →
  20. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
    2007 6.1k citations Jan P. Vandenbroucke, Erik von Elm et al. profile →
  21. The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
    2015 5.7k citations Cynthia D. Mulrow, Peter C Gøtzsche et al. Annals of Internal Medicine profile →
  22. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
    2011 5.5k citations James R. Carpenter, Jonathan J Deeks et al. BMJ profile →
  23. Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
    2010 5.5k citations Douglas G. Altman et al. profile →
  24. Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
    2010 5.5k citations Douglas G. Altman et al. profile →
  25. SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
    2013 4.4k citations Douglas G. Altman, Peter C Gøtzsche et al. Annals of Internal Medicine profile →
  26. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
    2001 4.2k citations David Moher, Kenneth F. Schulz et al. profile →
  27. Practical Statistics for Medical Research.
    1992 4.0k citations Douglas G. Altman et al. profile →
  28. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
    2013 3.6k citations Peter C Gøtzsche, Douglas G. Altman et al. profile →
  29. Measurement in Medicine: The Analysis of Method Comparison Studies
    1983 3.5k citations Douglas G. Altman et al. profile →
  30. Chapter 8: Assessing risk of bias in included studies
    2008 3.4k citations Douglas G. Altman et al. profile →
  31. Animal research: Reporting in vivo experiments: The ARRIVE guidelines
    2010 3.2k citations Douglas G. Altman et al. profile →
  32. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
    2015 3.1k citations Karel G.M. Moons, Douglas G. Altman et al. Annals of Internal Medicine profile →
  33. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
    2015 2.6k citations Gary S. Collins, Johannes B. Reitsma et al. profile →
  34. Interaction revisited: the difference between two estimates
    2003 2.4k citations Douglas G. Altman et al. BMJ profile →
  35. Chapter 9: Analysing Data and Undertaking Meta-Analyses
    2008 2.4k citations Jonathan J Deeks, Douglas G. Altman et al. profile →
  36. Evaluating non-randomised intervention studies
    2003 2.4k citations Jonathan J Deeks, Douglas G. Altman et al. profile →
  37. Statistical methods for assessing agreement between two methods of clinical measurement
    2010 2.3k citations Douglas G. Altman et al. profile →
  38. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
    2009 2.3k citations Douglas G. Altman, Cynthia D. Mulrow et al. profile →
  39. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
    2015 2.3k citations Gary S. Collins, Johannes B. Reitsma et al. profile →
  40. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
    2001 2.3k citations David Moher, Kenneth F. Schulz et al. profile →
  41. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies
    2015 2.2k citations Johannes B. Reitsma, David Moher et al. profile →
  42. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
    2007 2.1k citations Erik von Elm, Douglas G. Altman et al. profile →
  43. Systematic Reviews in Health Care : Meta-Analysis in Context
    2000 2.0k citations Matthias Egger, Douglas G. Altman et al. profile →
  44. Reprint—Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
    2009 2.0k citations David Moher, Douglas G. Altman et al. profile →
  45. Consort 2010 statement: extension to cluster randomised trials
    2012 2.0k citations Douglas G. Altman et al. profile →
  46. Comparing methods of measurement: why plotting difference against standard method is misleading
    1995 2.0k citations Douglas G. Altman et al. profile →
  47. CONSORT statement: extension to cluster randomised trials
    2004 1.9k citations Douglas G. Altman et al. BMJ profile →
  48. Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines
    2011 1.9k citations Douglas G. Altman et al. profile →
  49. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
    2007 1.9k citations Jan P. Vandenbroucke, Erik von Elm et al. Epidemiology profile →
  50. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration
    2014 1.9k citations Jan P. Vandenbroucke, Erik von Elm et al. profile →
  51. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study
    2008 1.9k citations Matthias Egger, Kenneth F. Schulz et al. profile →
  52. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
    2015 1.8k citations Gary S. Collins, Johannes B. Reitsma et al. Annals of Internal Medicine profile →
  53. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations
    2016 1.8k citations Douglas G. Altman et al. profile →
  54. The cost of dichotomising continuous variables
    2006 1.7k citations Douglas G. Altman et al. BMJ profile →
  55. Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration
    2008 1.7k citations Isabelle Boutron, David Moher et al. Annals of Internal Medicine profile →
  56. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
    2005 1.7k citations Douglas G. Altman, Willi Sauerbrei et al. profile →
  57. Meta-analyses involving cross-over trials: methodological issues
    2002 1.7k citations Douglas G. Altman et al. profile →
  58. CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials
    2010 1.7k citations Kenneth F. Schulz, Douglas G. Altman et al. profile →
  59. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
    2011 1.7k citations David Moher, Sally Hopewell et al. profile →
  60. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials
    2010 1.6k citations Kenneth F. Schulz, Douglas G. Altman et al. profile →
  61. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
    2016 1.6k citations Douglas G. Altman, Johannes B. Reitsma et al. BMJ Open profile →
  62. Dichotomizing continuous predictors in multiple regression: a bad idea
    2005 1.6k citations Douglas G. Altman, Willi Sauerbrei et al. profile →
  63. Statistics Notes: Diagnostic tests 1: sensitivity and specificity
    1994 1.5k citations Douglas G. Altman et al. BMJ profile →
  64. Analysing controlled trials with baseline and follow up measurements
    2001 1.5k citations Andrew J. Vickers, Douglas G. Altman BMJ profile →
  65. Confidence intervals rather than P values: estimation rather than hypothesis testing.
    1986 1.5k citations Douglas G. Altman et al. profile →
  66. Agreement Between Methods of Measurement with Multiple Observations Per Individual
    2007 1.4k citations Douglas G. Altman et al. profile →
  67. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
    2010 1.4k citations Kenneth F. Schulz, Douglas G. Altman et al. profile →
  68. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
    2010 1.4k citations David Moher, Sally Hopewell et al. Journal of Clinical Epidemiology profile →
  69. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement
    2007 1.3k citations Erik von Elm, Douglas G. Altman et al. Epidemiology profile →
  70. Statistics Notes: Diagnostic tests 2: predictive values
    1994 1.3k citations Douglas G. Altman et al. BMJ profile →
  71. Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist
    2014 1.3k citations Susan Mallett, Douglas G. Altman et al. profile →
  72. Reporting of Noninferiority and Equivalence Randomized Trials
    2012 1.3k citations Stuart Pocock, Stephen Evans et al. profile →
  73. Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials
    2004 1.2k citations Peter C Gøtzsche, Douglas G. Altman et al. profile →
  74. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement
    2015 1.2k citations Gary S. Collins, Johannes B. Reitsma et al. profile →
  75. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies*
    2007 1.2k citations Erik von Elm, Douglas G. Altman et al. profile →
  76. Diagnostic tests 4: likelihood ratios
    2004 1.2k citations Jonathan J Deeks, Douglas G. Altman BMJ profile →
  77. No surgical innovation without evaluation: the IDEAL recommendations
    2009 1.2k citations Douglas G. Altman et al. profile →
  78. The COMET Handbook: version 1.0
    2017 1.1k citations Douglas G. Altman et al. profile →
  79. What do we mean by validating a prognostic model?
    2000 1.1k citations Douglas G. Altman et al. profile →
  80. Applying the right statistics: analyses of measurement studies
    2003 1.1k citations Douglas G. Altman et al. profile →
  81. Metan: Fixed- and Random-Effects Meta-Analysis
    2008 890 citations Jonathan J Deeks, Douglas G. Altman et al. profile →
  82. Reporting of Noninferiority and Equivalence Randomized Trials
    2006 843 citations Douglas G. Altman, Stuart Pocock et al. profile →
  83. Guidance for Developers of Health Research Reporting Guidelines
    2010 796 citations David Moher, Kenneth F. Schulz et al. profile →
  84. Confidence intervals for the number needed to treat
    1998 716 citations Douglas G. Altman BMJ profile →
  85. Systematic reviews of evaluations of prognostic variables
    2001 633 citations Douglas G. Altman BMJ profile →
  86. The logrank test
    2004 631 citations Douglas G. Altman et al. BMJ profile →
  87. Epidemiology and Reporting Characteristics of Systematic Reviews
    2007 624 citations David Moher, Douglas G. Altman et al. profile →
  88. Reporting Recommendations for Tumor Marker Prognostic Studies
    2005 613 citations Douglas G. Altman, Willi Sauerbrei et al. Journal of Clinical Oncology profile →
  89. Calculating the number needed to treat for trials where the outcome is time to an event
    1999 536 citations Douglas G. Altman et al. BMJ profile →
  90. Treatment allocation by minimisation
    2005 404 citations Douglas G. Altman et al. BMJ profile →
  91. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa
    2012 400 citations Lucy Turner, Larissa Shamseer et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Douglas G. Altman 110.5k 75.4k 73.6k 65.7k 55.7k 655 618.4k
David Moher 87.8k 0.8× 57.3k 0.8× 66.6k 0.9× 48.1k 0.7× 39.5k 0.7× 815 506.2k
Jennifer Tetzlaff 50.2k 0.5× 32.2k 0.4× 32.9k 0.4× 28.1k 0.4× 21.9k 0.4× 42 273.2k
Peter C Gøtzsche 41.2k 0.4× 25.8k 0.3× 25.8k 0.4× 23.5k 0.4× 20.1k 0.4× 295 204.5k
Matthias Egger 37.1k 0.3× 32.9k 0.4× 25.2k 0.3× 20.4k 0.3× 18.7k 0.3× 780 212.8k
Alessandro Liberati 34.5k 0.3× 22.3k 0.3× 24.0k 0.3× 19.2k 0.3× 14.8k 0.3× 87 193.0k
Julian P. T. Higgins 34.4k 0.3× 23.9k 0.3× 18.9k 0.3× 23.0k 0.4× 18.8k 0.3× 471 205.3k
George Davey Smith 23.5k 0.2× 26.8k 0.4× 32.5k 0.4× 14.4k 0.2× 19.6k 0.4× 2.0k 218.3k
Gordon Guyatt 33.7k 0.3× 23.0k 0.3× 24.1k 0.3× 29.7k 0.5× 20.0k 0.4× 1.4k 174.1k
John P. A. Ioannidis 25.9k 0.2× 17.9k 0.2× 20.6k 0.3× 16.1k 0.2× 15.3k 0.3× 1.1k 189.3k
Walter C. Willett 18.9k 0.2× 20.9k 0.3× 98.0k 1.3× 12.3k 0.2× 16.1k 0.3× 1.9k 255.3k

Countries citing papers authored by Douglas G. Altman

Since Specialization
Citations

This map shows the geographic impact of Douglas G. Altman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas G. Altman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas G. Altman more than expected).

Fields of papers citing papers by Douglas G. Altman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas G. Altman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas G. Altman. The network helps show where Douglas G. Altman may publish in the future.

Co-authorship network of co-authors of Douglas G. Altman

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas G. Altman. A scholar is included among the top collaborators of Douglas G. Altman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas G. Altman. Douglas G. Altman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moons, Karel G.M., Douglas G. Altman, Johannes B. Reitsma, et al.. (2023). Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): Explanation and Elaboration. Translation into Russian. SHILAP Revista de lepidopterología. 22(2). 109–187. 1 indexed citations
2.
Barber, Melissa S., Jeffrey K Aronson, Tido von Schoen-Angerer, et al.. (2022). CARE guidelines for case reports: explanation and elaboration document. Translation into Russian. SHILAP Revista de lepidopterología. 3(1). 16–42. 1 indexed citations
3.
Moons, Karel G.M., Douglas G. Altman, Johannes B. Reitsma, et al.. (2022). Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration. Translation in to Russian. SHILAP Revista de lepidopterología. 3(3). 232–322. 3 indexed citations
4.
Gail, Mitchell H., Douglas G. Altman, Suzanne M. Cadarette, et al.. (2019). Design choices for observational studies of the effect of exposure on disease incidence. BMJ Open. 9(12). e031031–e031031. 30 indexed citations
5.
Benedetto, Umberto, Douglas G. Altman, Stephen Gerry, et al.. (2018). Northumbria Research Link (Northumbria University). 8 indexed citations
6.
Sekula, Peggy, Susan Mallett, Douglas G. Altman, & Willi Sauerbrei. (2017). Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles. PLoS ONE. 12(6). e0178531–e0178531. 29 indexed citations
7.
Wieland, L. Susan, Brian Berman, Douglas G. Altman, et al.. (2017). Rating of Included Trials on the Efficacy–Effectiveness Spectrum: development of a new tool for systematic reviews. Journal of Clinical Epidemiology. 84. 95–104. 33 indexed citations
8.
Papageorghiou, Aris T., Eric O. Ohuma, Michael G. Gravett, et al.. (2017). International Standards for Symphysis-Fundal Height Based on Serial Measurements From the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project: Prospective Cohort Study in Eight Countries. Obstetrical & Gynecological Survey. 72(3). 141–143. 10 indexed citations
9.
Odutayo, Ayodele, Christopher X. Wong, Michael E. Farkouh, et al.. (2016). AKI and Long-Term Risk for Cardiovascular Events and Mortality. Journal of the American Society of Nephrology. 28(1). 377–387. 271 indexed citations breakdown →
10.
Ismail, Leila Cheikh, Francesca Giuliani, Deborah C. Bishop, et al.. (2016). Preterm feeding recommendations are achievable in large-scale research studies. BMC Nutrition. 2(1). 9 indexed citations
11.
Boutron, Isabelle, Douglas G. Altman, Sally Hopewell, et al.. (2014). Impact of Spin in the Abstracts of Articles Reporting Results of Randomized Controlled Trials in the Field of Cancer: The SPIIN Randomized Controlled Trial. Journal of Clinical Oncology. 32(36). 4120–4126. 246 indexed citations
12.
Gagnier, Joel, Gunver S. Kienle, Douglas G. Altman, et al.. (2013). The CARE Guidelines: Consensus-based Clinical Case Report Guideline Development. Journal of Dietary Supplements. 10(4). 381–390. 109 indexed citations
13.
Turner, Lucy, Larissa Shamseer, Douglas G. Altman, et al.. (2012). Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database of Systematic Reviews. 2013(1). MR000030–MR000030. 531 indexed citations breakdown →
14.
MacPherson, Hugh, Douglas G. Altman, Richard Hammerschlag, et al.. (2010). Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT Statement. The Journal of Alternative and Complementary Medicine. 16(10). ST–1. 217 indexed citations
15.
Vandenbroucke, Jan P., Erik von Elm, Douglas G. Altman, et al.. (2009). Mejorar la comunicación de estudios observacionales en epidemiología (STROBE): explicación y elaboración Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. SHILAP Revista de lepidopterología. 28 indexed citations
16.
Elm, Erik von, Douglas G. Altman, Matthias Egger, et al.. (2008). Declaración de la Iniciativa STROBE (Strengthening the Reporting of Observational studies in Epidemiology): directrices para la comunicación de estudios observacionales The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Vandenbroucke, Jan P., Erik von Elm, Douglas G. Altman, et al.. (2007). Strengthening the Reporting of Observational Studies in Epidemiology (STROBE). Epidemiology. 18(6). 805–835. 1858 indexed citations breakdown →
18.
Moher, David, et al.. (2001). The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials. Annals of Internal Medicine. 134(8). 657–662. 1023 indexed citations breakdown →
19.
Deeks, Jonathan J, Keith Hawton, S. Simkin, et al.. (1999). Effects of a drug overdose in a television drama on knowledge of specific dangers of self poisoning: population based surveys. BMJ. 318(7189). 978–979. 13 indexed citations
20.
Altman, Douglas G.. (1991). Medical Statistics: A Commonsense Approach. Journal of the Royal College of Physicians of London. 25(1). 75–76. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Moher Breakdown of academic impact, for papers by Jennifer Tetzlaff Breakdown of academic impact, for papers by Peter C Gøtzsche Breakdown of academic impact, for papers by Matthias Egger Breakdown of academic impact, for papers by Alessandro Liberati Breakdown of academic impact, for papers by Julian P. T. Higgins Breakdown of academic impact, for papers by George Davey Smith Breakdown of academic impact, for papers by Gordon Guyatt Breakdown of academic impact, for papers by John P. A. Ioannidis Breakdown of academic impact, for papers by Walter C. Willett
Rankless by CCL
2026